| # | Drug | Count |
|---|---|---|
| 0 | AZACITIDINE | 13 |
| 1 | VENETOCLAX | 13 |
| 2 | AZACITIDINE FOR | 12 |
| 3 | VORICONAZOLE | 2 |
| 4 | VORICONAZOLE INJECTION | 2 |
| 5 | FILGRASTIM | 1 |
| 6 | HYDROXYUREA | 1 |
| 7 | OLUTASIDENIB | 1 |
| 8 | POSACONAZOLE | 1 |
| 9 | POSACONAZOLE DELAYED-RELEASE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLUTASIDENIB | 1 | 0.0035 |
| 1 | QUIZARTINIB | 1 | 0.0014 |
| 2 | AZACITIDINE | 13 | 0.0004 |
| 3 | VENETOCLAX | 13 | 0.0002 |
| 4 | VORICONAZOLE | 2 | 0.0001 |
| 5 | POSACONAZOLE | 1 | 0.0001 |
| 6 | HYDROXYUREA | 1 | 0.0000 |
| 7 | FILGRASTIM | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 13 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 2 | Azole Antifungal [EPC] | 3 |
| 3 | Antimetabolite [EPC] | 1 |
| 4 | Leukocyte Growth Factor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 13 | 0.0002 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 13 | 0.0000 |
| 2 | Azole Antifungal [EPC] | 3 | 0.0000 |
| 3 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |